nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Methotrexate—esophageal cancer	0.171	0.424	CbGbCtD
Gemfibrozil—CYP2C9—Capecitabine—esophageal cancer	0.154	0.383	CbGbCtD
Gemfibrozil—CYP2C9—Cisplatin—esophageal cancer	0.0777	0.193	CbGbCtD
Gemfibrozil—Reaction gastrointestinal—Methotrexate—esophageal cancer	0.00423	0.0287	CcSEcCtD
Gemfibrozil—Bacterial infection—Methotrexate—esophageal cancer	0.00306	0.0207	CcSEcCtD
Gemfibrozil—Bone marrow depression—Capecitabine—esophageal cancer	0.00281	0.019	CcSEcCtD
Gemfibrozil—Pain—Carboplatin—esophageal cancer	0.00268	0.0181	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Capecitabine—esophageal cancer	0.00242	0.0164	CcSEcCtD
Gemfibrozil—Extrasystoles—Capecitabine—esophageal cancer	0.00226	0.0153	CcSEcCtD
Gemfibrozil—Bone marrow depression—Methotrexate—esophageal cancer	0.00209	0.0142	CcSEcCtD
Gemfibrozil—Blood bilirubin increased—Capecitabine—esophageal cancer	0.00201	0.0136	CcSEcCtD
Gemfibrozil—Cataract—Capecitabine—esophageal cancer	0.00199	0.0135	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.0019	0.0128	CcSEcCtD
Gemfibrozil—Colitis—Capecitabine—esophageal cancer	0.00182	0.0123	CcSEcCtD
Gemfibrozil—Breast disorder—Cisplatin—esophageal cancer	0.00169	0.0114	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Cisplatin—esophageal cancer	0.00167	0.0113	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00158	0.0107	CcSEcCtD
Gemfibrozil—Pancreatitis—Cisplatin—esophageal cancer	0.00158	0.0107	CcSEcCtD
Gemfibrozil—Photosensitivity—Capecitabine—esophageal cancer	0.00157	0.0106	CcSEcCtD
Gemfibrozil—Pancytopenia—Cisplatin—esophageal cancer	0.00153	0.0104	CcSEcCtD
Gemfibrozil—Libido decreased—Capecitabine—esophageal cancer	0.00149	0.0101	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.00146	0.00988	CcSEcCtD
Gemfibrozil—Atrial fibrillation—Capecitabine—esophageal cancer	0.00145	0.00984	CcSEcCtD
Gemfibrozil—Vasculitis—Methotrexate—esophageal cancer	0.00145	0.0098	CcSEcCtD
Gemfibrozil—Renal failure—Cisplatin—esophageal cancer	0.00142	0.00958	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00141	0.00956	CcSEcCtD
Gemfibrozil—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00137	0.00925	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00136	0.00922	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Capecitabine—esophageal cancer	0.00127	0.00861	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Cisplatin—esophageal cancer	0.00127	0.0086	CcSEcCtD
Gemfibrozil—Abdominal pain upper—Capecitabine—esophageal cancer	0.00126	0.00852	CcSEcCtD
Gemfibrozil—Breast disorder—Capecitabine—esophageal cancer	0.00125	0.00843	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Capecitabine—esophageal cancer	0.00123	0.00834	CcSEcCtD
Gemfibrozil—Muscular weakness—Capecitabine—esophageal cancer	0.00122	0.00822	CcSEcCtD
Gemfibrozil—Eye disorder—Cisplatin—esophageal cancer	0.00121	0.00818	CcSEcCtD
Gemfibrozil—Photosensitivity—Methotrexate—esophageal cancer	0.00117	0.00791	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Cisplatin—esophageal cancer	0.00117	0.00789	CcSEcCtD
Gemfibrozil—Alopecia—Cisplatin—esophageal cancer	0.00114	0.00773	CcSEcCtD
Gemfibrozil—Pancytopenia—Capecitabine—esophageal cancer	0.00113	0.00765	CcSEcCtD
Gemfibrozil—Flatulence—Cisplatin—esophageal cancer	0.00111	0.00751	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.00109	0.00736	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00109	0.00736	CcSEcCtD
Gemfibrozil—Weight decreased—Capecitabine—esophageal cancer	0.00108	0.00729	CcSEcCtD
Gemfibrozil—Vision blurred—Cisplatin—esophageal cancer	0.00106	0.00718	CcSEcCtD
Gemfibrozil—Depression—Capecitabine—esophageal cancer	0.00106	0.00717	CcSEcCtD
Gemfibrozil—Renal failure—Capecitabine—esophageal cancer	0.00104	0.00706	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00104	0.00704	CcSEcCtD
Gemfibrozil—Anaemia—Cisplatin—esophageal cancer	0.00104	0.00704	CcSEcCtD
Gemfibrozil—Jaundice—Capecitabine—esophageal cancer	0.00104	0.007	CcSEcCtD
Gemfibrozil—Urinary tract infection—Capecitabine—esophageal cancer	0.00103	0.00699	CcSEcCtD
Gemfibrozil—Leukopenia—Cisplatin—esophageal cancer	0.00101	0.00682	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Capecitabine—esophageal cancer	0.001	0.0068	CcSEcCtD
Gemfibrozil—Convulsion—Cisplatin—esophageal cancer	0.000975	0.0066	CcSEcCtD
Gemfibrozil—Myalgia—Cisplatin—esophageal cancer	0.000958	0.00649	CcSEcCtD
Gemfibrozil—Rhinitis—Capecitabine—esophageal cancer	0.000956	0.00647	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000952	0.00644	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Capecitabine—esophageal cancer	0.000948	0.00642	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Methotrexate—esophageal cancer	0.000947	0.00641	CcSEcCtD
Gemfibrozil—Connective tissue disorder—Capecitabine—esophageal cancer	0.000937	0.00634	CcSEcCtD
Gemfibrozil—Breast disorder—Methotrexate—esophageal cancer	0.000927	0.00627	CcSEcCtD
Gemfibrozil—Oedema—Cisplatin—esophageal cancer	0.000919	0.00622	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Cisplatin—esophageal cancer	0.000919	0.00622	CcSEcCtD
Gemfibrozil—Nervous system disorder—Cisplatin—esophageal cancer	0.000901	0.0061	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Cisplatin—esophageal cancer	0.0009	0.00609	CcSEcCtD
Gemfibrozil—Skin disorder—Cisplatin—esophageal cancer	0.000892	0.00604	CcSEcCtD
Gemfibrozil—Eye disorder—Capecitabine—esophageal cancer	0.000891	0.00603	CcSEcCtD
Gemfibrozil—Eosinophilia—Methotrexate—esophageal cancer	0.000878	0.00594	CcSEcCtD
Gemfibrozil—Pancreatitis—Methotrexate—esophageal cancer	0.000869	0.00588	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Capecitabine—esophageal cancer	0.000859	0.00581	CcSEcCtD
Gemfibrozil—Alopecia—Capecitabine—esophageal cancer	0.000842	0.0057	CcSEcCtD
Gemfibrozil—Pancytopenia—Methotrexate—esophageal cancer	0.000842	0.0057	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000837	0.00566	CcSEcCtD
Gemfibrozil—Mental disorder—Capecitabine—esophageal cancer	0.000835	0.00565	CcSEcCtD
Gemfibrozil—Paraesthesia—Cisplatin—esophageal cancer	0.000825	0.00558	CcSEcCtD
Gemfibrozil—Flatulence—Capecitabine—esophageal cancer	0.000818	0.00553	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Methotrexate—esophageal cancer	0.000817	0.00553	CcSEcCtD
Gemfibrozil—Dysgeusia—Capecitabine—esophageal cancer	0.000813	0.0055	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000809	0.00548	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000793	0.00537	CcSEcCtD
Gemfibrozil—Depression—Methotrexate—esophageal cancer	0.000788	0.00533	CcSEcCtD
Gemfibrozil—Pain—Cisplatin—esophageal cancer	0.000786	0.00532	CcSEcCtD
Gemfibrozil—Vision blurred—Capecitabine—esophageal cancer	0.000782	0.00529	CcSEcCtD
Gemfibrozil—Renal failure—Methotrexate—esophageal cancer	0.000777	0.00526	CcSEcCtD
Gemfibrozil—Anaemia—Capecitabine—esophageal cancer	0.000767	0.00519	CcSEcCtD
Gemfibrozil—Feeling abnormal—Cisplatin—esophageal cancer	0.000757	0.00512	CcSEcCtD
Gemfibrozil—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000748	0.00506	CcSEcCtD
Gemfibrozil—Vertigo—Capecitabine—esophageal cancer	0.000746	0.00505	CcSEcCtD
Gemfibrozil—Syncope—Capecitabine—esophageal cancer	0.000744	0.00504	CcSEcCtD
Gemfibrozil—Leukopenia—Capecitabine—esophageal cancer	0.000743	0.00503	CcSEcCtD
Gemfibrozil—Loss of consciousness—Capecitabine—esophageal cancer	0.000729	0.00494	CcSEcCtD
Gemfibrozil—Cough—Capecitabine—esophageal cancer	0.000724	0.0049	CcSEcCtD
Gemfibrozil—Arthralgia—Capecitabine—esophageal cancer	0.000706	0.00478	CcSEcCtD
Gemfibrozil—Chest pain—Capecitabine—esophageal cancer	0.000706	0.00478	CcSEcCtD
Gemfibrozil—Myalgia—Capecitabine—esophageal cancer	0.000706	0.00478	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000702	0.00475	CcSEcCtD
Gemfibrozil—Confusional state—Capecitabine—esophageal cancer	0.000683	0.00462	CcSEcCtD
Gemfibrozil—Oedema—Capecitabine—esophageal cancer	0.000677	0.00458	CcSEcCtD
Gemfibrozil—Shock—Capecitabine—esophageal cancer	0.000666	0.00451	CcSEcCtD
Gemfibrozil—Nervous system disorder—Capecitabine—esophageal cancer	0.000664	0.00449	CcSEcCtD
Gemfibrozil—Eye disorder—Methotrexate—esophageal cancer	0.000663	0.00449	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Capecitabine—esophageal cancer	0.000663	0.00449	CcSEcCtD
Gemfibrozil—Asthenia—Cisplatin—esophageal cancer	0.000659	0.00446	CcSEcCtD
Gemfibrozil—Skin disorder—Capecitabine—esophageal cancer	0.000658	0.00445	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Methotrexate—esophageal cancer	0.00064	0.00433	CcSEcCtD
Gemfibrozil—Diarrhoea—Cisplatin—esophageal cancer	0.000629	0.00425	CcSEcCtD
Gemfibrozil—Alopecia—Methotrexate—esophageal cancer	0.000627	0.00424	CcSEcCtD
Gemfibrozil—Mental disorder—Methotrexate—esophageal cancer	0.000622	0.00421	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000617	0.00418	CcSEcCtD
Gemfibrozil—Paraesthesia—Capecitabine—esophageal cancer	0.000608	0.00412	CcSEcCtD
Gemfibrozil—Dysgeusia—Methotrexate—esophageal cancer	0.000605	0.00409	CcSEcCtD
Gemfibrozil—Dyspepsia—Capecitabine—esophageal cancer	0.000596	0.00403	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000585	0.00396	CcSEcCtD
Gemfibrozil—Vomiting—Cisplatin—esophageal cancer	0.000584	0.00395	CcSEcCtD
Gemfibrozil—Fatigue—Capecitabine—esophageal cancer	0.000584	0.00395	CcSEcCtD
Gemfibrozil—Vision blurred—Methotrexate—esophageal cancer	0.000582	0.00394	CcSEcCtD
Gemfibrozil—Rash—Cisplatin—esophageal cancer	0.000579	0.00392	CcSEcCtD
Gemfibrozil—Constipation—Capecitabine—esophageal cancer	0.000579	0.00392	CcSEcCtD
Gemfibrozil—Pain—Capecitabine—esophageal cancer	0.000579	0.00392	CcSEcCtD
Gemfibrozil—Dermatitis—Cisplatin—esophageal cancer	0.000579	0.00392	CcSEcCtD
Gemfibrozil—Anaemia—Methotrexate—esophageal cancer	0.000571	0.00386	CcSEcCtD
Gemfibrozil—Feeling abnormal—Capecitabine—esophageal cancer	0.000558	0.00378	CcSEcCtD
Gemfibrozil—Vertigo—Methotrexate—esophageal cancer	0.000555	0.00376	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000554	0.00375	CcSEcCtD
Gemfibrozil—Leukopenia—Methotrexate—esophageal cancer	0.000553	0.00374	CcSEcCtD
Gemfibrozil—Nausea—Cisplatin—esophageal cancer	0.000546	0.00369	CcSEcCtD
Gemfibrozil—Cough—Methotrexate—esophageal cancer	0.000539	0.00365	CcSEcCtD
Gemfibrozil—Urticaria—Capecitabine—esophageal cancer	0.000538	0.00364	CcSEcCtD
Gemfibrozil—Abdominal pain—Capecitabine—esophageal cancer	0.000535	0.00362	CcSEcCtD
Gemfibrozil—Convulsion—Methotrexate—esophageal cancer	0.000535	0.00362	CcSEcCtD
Gemfibrozil—Arthralgia—Methotrexate—esophageal cancer	0.000526	0.00356	CcSEcCtD
Gemfibrozil—Chest pain—Methotrexate—esophageal cancer	0.000526	0.00356	CcSEcCtD
Gemfibrozil—Myalgia—Methotrexate—esophageal cancer	0.000526	0.00356	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000522	0.00353	CcSEcCtD
Gemfibrozil—Confusional state—Methotrexate—esophageal cancer	0.000508	0.00344	CcSEcCtD
Gemfibrozil—Anaphylactic shock—Methotrexate—esophageal cancer	0.000504	0.00341	CcSEcCtD
Gemfibrozil—Nervous system disorder—Methotrexate—esophageal cancer	0.000494	0.00335	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Methotrexate—esophageal cancer	0.000494	0.00334	CcSEcCtD
Gemfibrozil—Skin disorder—Methotrexate—esophageal cancer	0.00049	0.00331	CcSEcCtD
Gemfibrozil—Asthenia—Capecitabine—esophageal cancer	0.000486	0.00329	CcSEcCtD
Gemfibrozil—Pruritus—Capecitabine—esophageal cancer	0.000479	0.00324	CcSEcCtD
Gemfibrozil—Diarrhoea—Capecitabine—esophageal cancer	0.000463	0.00314	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000459	0.00311	CcSEcCtD
Gemfibrozil—Paraesthesia—Methotrexate—esophageal cancer	0.000453	0.00306	CcSEcCtD
Gemfibrozil—Somnolence—Methotrexate—esophageal cancer	0.000448	0.00303	CcSEcCtD
Gemfibrozil—Dizziness—Capecitabine—esophageal cancer	0.000448	0.00303	CcSEcCtD
Gemfibrozil—Dyspepsia—Methotrexate—esophageal cancer	0.000444	0.003	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000435	0.00295	CcSEcCtD
Gemfibrozil—Fatigue—Methotrexate—esophageal cancer	0.000435	0.00294	CcSEcCtD
Gemfibrozil—Pain—Methotrexate—esophageal cancer	0.000431	0.00292	CcSEcCtD
Gemfibrozil—Vomiting—Capecitabine—esophageal cancer	0.000431	0.00291	CcSEcCtD
Gemfibrozil—Rash—Capecitabine—esophageal cancer	0.000427	0.00289	CcSEcCtD
Gemfibrozil—Dermatitis—Capecitabine—esophageal cancer	0.000427	0.00289	CcSEcCtD
Gemfibrozil—Headache—Capecitabine—esophageal cancer	0.000424	0.00287	CcSEcCtD
Gemfibrozil—Feeling abnormal—Methotrexate—esophageal cancer	0.000415	0.00281	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000412	0.00279	CcSEcCtD
Gemfibrozil—Nausea—Capecitabine—esophageal cancer	0.000402	0.00272	CcSEcCtD
Gemfibrozil—Urticaria—Methotrexate—esophageal cancer	0.000401	0.00271	CcSEcCtD
Gemfibrozil—Abdominal pain—Methotrexate—esophageal cancer	0.000399	0.0027	CcSEcCtD
Gemfibrozil—Asthenia—Methotrexate—esophageal cancer	0.000362	0.00245	CcSEcCtD
Gemfibrozil—Pruritus—Methotrexate—esophageal cancer	0.000357	0.00241	CcSEcCtD
Gemfibrozil—Diarrhoea—Methotrexate—esophageal cancer	0.000345	0.00233	CcSEcCtD
Gemfibrozil—Dizziness—Methotrexate—esophageal cancer	0.000333	0.00226	CcSEcCtD
Gemfibrozil—Vomiting—Methotrexate—esophageal cancer	0.000321	0.00217	CcSEcCtD
Gemfibrozil—Rash—Methotrexate—esophageal cancer	0.000318	0.00215	CcSEcCtD
Gemfibrozil—Dermatitis—Methotrexate—esophageal cancer	0.000318	0.00215	CcSEcCtD
Gemfibrozil—Headache—Methotrexate—esophageal cancer	0.000316	0.00214	CcSEcCtD
Gemfibrozil—Nausea—Methotrexate—esophageal cancer	0.000299	0.00203	CcSEcCtD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000177	0.000394	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TYMP—esophageal cancer	0.000177	0.000393	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000176	0.000391	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000176	0.000391	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP1B1—esophageal cancer	0.000175	0.000389	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000174	0.000386	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP26A1—esophageal cancer	0.000172	0.000382	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000168	0.000374	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—BLVRB—esophageal cancer	0.000168	0.000373	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC52A3—esophageal cancer	0.000168	0.000373	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALOX15—esophageal cancer	0.000167	0.000373	CbGpPWpGaD
Gemfibrozil—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000167	0.000372	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000165	0.000367	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EP300—esophageal cancer	0.000165	0.000367	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CYP19A1—esophageal cancer	0.000164	0.000366	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTO1—esophageal cancer	0.00016	0.000355	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—TPI1—esophageal cancer	0.00016	0.000355	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000153	0.000341	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALDOB—esophageal cancer	0.000153	0.000341	CbGpPWpGaD
Gemfibrozil—PPARA—Generic Transcription Pathway—MYC—esophageal cancer	0.000153	0.00034	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00015	0.000334	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—HMOX1—esophageal cancer	0.00015	0.000334	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.00015	0.000333	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC52A3—esophageal cancer	0.00015	0.000333	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—BLVRB—esophageal cancer	0.00015	0.000333	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GAPDH—esophageal cancer	0.000147	0.000328	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	0.000147	0.000328	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CRABP1—esophageal cancer	0.000146	0.000325	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—ABCB1—esophageal cancer	0.000144	0.00032	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA1—esophageal cancer	0.000142	0.000317	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—SLC10A2—esophageal cancer	0.000142	0.000317	CbGpPWpGaD
Gemfibrozil—PPARA—Developmental Biology—EGFR—esophageal cancer	0.00014	0.000313	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GNG7—esophageal cancer	0.000139	0.000309	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—NOTCH1—esophageal cancer	0.000137	0.000304	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000136	0.000303	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000136	0.000303	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000134	0.000297	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000131	0.000292	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CA2—esophageal cancer	0.00013	0.00029	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ALDH2—esophageal cancer	0.00013	0.00029	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000127	0.000283	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—SLC10A2—esophageal cancer	0.000127	0.000283	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA1—esophageal cancer	0.000127	0.000283	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—GSTT1—esophageal cancer	0.000124	0.000276	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—CREBBP—esophageal cancer	0.000124	0.000275	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	0.000122	0.000272	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000122	0.000271	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000122	0.000271	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ADH7—esophageal cancer	0.000121	0.00027	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PLCE1—esophageal cancer	0.000121	0.00027	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.00012	0.000266	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC52A3—esophageal cancer	0.000117	0.000259	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—BLVRB—esophageal cancer	0.000117	0.000259	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CA2—esophageal cancer	0.000116	0.000259	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ENO1—esophageal cancer	0.000116	0.000258	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS1—esophageal cancer	0.000116	0.000258	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000116	0.000258	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA1—esophageal cancer	0.000116	0.000258	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000116	0.000258	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSME1—esophageal cancer	0.000114	0.000254	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PSME2—esophageal cancer	0.000114	0.000254	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000114	0.000253	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	0.000109	0.000242	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PLCE1—esophageal cancer	0.000108	0.000241	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ADH7—esophageal cancer	0.000108	0.000241	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000107	0.000238	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ADH1B—esophageal cancer	0.000106	0.000236	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CA2—esophageal cancer	0.000106	0.000236	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000104	0.000232	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000104	0.000231	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TYMP—esophageal cancer	0.000101	0.000226	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.99e-05	0.000222	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—SLC10A2—esophageal cancer	9.91e-05	0.00022	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA1—esophageal cancer	9.91e-05	0.00022	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP26A1—esophageal cancer	9.87e-05	0.00022	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	9.87e-05	0.00022	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ADH7—esophageal cancer	9.86e-05	0.000219	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PLCE1—esophageal cancer	9.86e-05	0.000219	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.74e-05	0.000217	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—CREBBP—esophageal cancer	9.62e-05	0.000214	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALOX15—esophageal cancer	9.62e-05	0.000214	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ADH1B—esophageal cancer	9.48e-05	0.000211	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	9.28e-05	0.000206	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTO1—esophageal cancer	9.18e-05	0.000204	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—TPI1—esophageal cancer	9.18e-05	0.000204	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CA2—esophageal cancer	9.06e-05	0.000202	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TYMP—esophageal cancer	9.06e-05	0.000202	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.99e-05	0.0002	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.99e-05	0.0002	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.86e-05	0.000197	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP26A1—esophageal cancer	8.81e-05	0.000196	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALDOB—esophageal cancer	8.8e-05	0.000196	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ADH1B—esophageal cancer	8.64e-05	0.000192	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—NOS3—esophageal cancer	8.62e-05	0.000192	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALOX15—esophageal cancer	8.59e-05	0.000191	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GAPDH—esophageal cancer	8.47e-05	0.000189	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—HMOX1—esophageal cancer	8.47e-05	0.000188	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PLCE1—esophageal cancer	8.42e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ADH7—esophageal cancer	8.42e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CRABP1—esophageal cancer	8.4e-05	0.000187	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.33e-05	0.000185	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.31e-05	0.000185	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TYMP—esophageal cancer	8.26e-05	0.000184	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—TPI1—esophageal cancer	8.19e-05	0.000182	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTO1—esophageal cancer	8.19e-05	0.000182	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—ABCB1—esophageal cancer	8.13e-05	0.000181	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP26A1—esophageal cancer	8.04e-05	0.000179	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GNG7—esophageal cancer	7.99e-05	0.000178	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PTGS2—esophageal cancer	7.88e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALDOB—esophageal cancer	7.86e-05	0.000175	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALOX15—esophageal cancer	7.83e-05	0.000174	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA1—esophageal cancer	7.65e-05	0.00017	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—SLC10A2—esophageal cancer	7.65e-05	0.00017	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GAPDH—esophageal cancer	7.56e-05	0.000168	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CRABP1—esophageal cancer	7.49e-05	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ALDH2—esophageal cancer	7.48e-05	0.000167	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—TPI1—esophageal cancer	7.47e-05	0.000166	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTO1—esophageal cancer	7.47e-05	0.000166	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ADH1B—esophageal cancer	7.39e-05	0.000164	CbGpPWpGaD
Gemfibrozil—PPARA—Gene Expression—MYC—esophageal cancer	7.35e-05	0.000163	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALDOB—esophageal cancer	7.16e-05	0.000159	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GNG7—esophageal cancer	7.13e-05	0.000159	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—GSTT1—esophageal cancer	7.12e-05	0.000158	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TYMP—esophageal cancer	7.06e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP2A6—esophageal cancer	7.04e-05	0.000157	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.01e-05	0.000156	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CA2—esophageal cancer	6.99e-05	0.000156	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GAPDH—esophageal cancer	6.89e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP26A1—esophageal cancer	6.87e-05	0.000153	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CRABP1—esophageal cancer	6.83e-05	0.000152	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALOX15—esophageal cancer	6.69e-05	0.000149	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ALDH2—esophageal cancer	6.68e-05	0.000149	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ENO1—esophageal cancer	6.67e-05	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS1—esophageal cancer	6.67e-05	0.000148	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSME1—esophageal cancer	6.57e-05	0.000146	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PSME2—esophageal cancer	6.57e-05	0.000146	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—EP300—esophageal cancer	6.56e-05	0.000146	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ADH7—esophageal cancer	6.5e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PLCE1—esophageal cancer	6.5e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GNG7—esophageal cancer	6.5e-05	0.000145	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—TPI1—esophageal cancer	6.38e-05	0.000142	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTO1—esophageal cancer	6.38e-05	0.000142	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—GSTT1—esophageal cancer	6.35e-05	0.000141	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP2A6—esophageal cancer	6.28e-05	0.00014	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.26e-05	0.000139	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.14e-05	0.000137	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDOB—esophageal cancer	6.12e-05	0.000136	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ALDH2—esophageal cancer	6.09e-05	0.000136	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS1—esophageal cancer	5.95e-05	0.000132	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ENO1—esophageal cancer	5.95e-05	0.000132	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GAPDH—esophageal cancer	5.89e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSME2—esophageal cancer	5.87e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PSME1—esophageal cancer	5.87e-05	0.000131	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CRABP1—esophageal cancer	5.84e-05	0.00013	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—GSTT1—esophageal cancer	5.79e-05	0.000129	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.74e-05	0.000128	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP2A6—esophageal cancer	5.73e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.7e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.7e-05	0.000127	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP1B1—esophageal cancer	5.67e-05	0.000126	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GNG7—esophageal cancer	5.55e-05	0.000124	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TYMP—esophageal cancer	5.45e-05	0.000121	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—CREBBP—esophageal cancer	5.43e-05	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ENO1—esophageal cancer	5.43e-05	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS1—esophageal cancer	5.43e-05	0.000121	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSME1—esophageal cancer	5.35e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PSME2—esophageal cancer	5.35e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CYP19A1—esophageal cancer	5.33e-05	0.000119	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.3e-05	0.000118	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ALDH2—esophageal cancer	5.2e-05	0.000116	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.16e-05	0.000115	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.12e-05	0.000114	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP1B1—esophageal cancer	5.06e-05	0.000113	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—GSTT1—esophageal cancer	4.95e-05	0.00011	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.93e-05	0.00011	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—TPI1—esophageal cancer	4.93e-05	0.00011	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP2A6—esophageal cancer	4.89e-05	0.000109	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.87e-05	0.000108	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—HMOX1—esophageal cancer	4.87e-05	0.000108	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—NOS3—esophageal cancer	4.86e-05	0.000108	CbGpPWpGaD
Gemfibrozil—PPARA—Metabolism—PIK3CA—esophageal cancer	4.85e-05	0.000108	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.77e-05	0.000106	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CYP19A1—esophageal cancer	4.76e-05	0.000106	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.72e-05	0.000105	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.67e-05	0.000104	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—ABCB1—esophageal cancer	4.67e-05	0.000104	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS1—esophageal cancer	4.64e-05	0.000103	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ENO1—esophageal cancer	4.64e-05	0.000103	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP1B1—esophageal cancer	4.62e-05	0.000103	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSME2—esophageal cancer	4.57e-05	0.000102	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PSME1—esophageal cancer	4.57e-05	0.000102	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.55e-05	0.000101	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.51e-05	0.0001	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PTGS2—esophageal cancer	4.45e-05	9.9e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—HMOX1—esophageal cancer	4.34e-05	9.66e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CYP19A1—esophageal cancer	4.34e-05	9.66e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GNG7—esophageal cancer	4.29e-05	9.54e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.26e-05	9.48e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—ABCB1—esophageal cancer	4.17e-05	9.28e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.02e-05	8.94e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.99e-05	8.88e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.96e-05	8.81e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP1B1—esophageal cancer	3.94e-05	8.78e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.88e-05	8.64e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.82e-05	8.5e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—ABCB1—esophageal cancer	3.8e-05	8.46e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.78e-05	8.4e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CYP19A1—esophageal cancer	3.71e-05	8.25e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—EP300—esophageal cancer	3.7e-05	8.23e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ENO1—esophageal cancer	3.58e-05	7.97e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.58e-05	7.97e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.53e-05	7.86e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSME2—esophageal cancer	3.53e-05	7.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PSME1—esophageal cancer	3.53e-05	7.85e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.38e-05	7.53e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.32e-05	7.39e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.25e-05	7.23e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.15e-05	7.01e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.12e-05	6.95e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.04e-05	6.77e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.87e-05	6.39e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.86e-05	6.37e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—NOS3—esophageal cancer	2.79e-05	6.22e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.79e-05	6.2e-05	CbGpPWpGaD
Gemfibrozil—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	2.74e-05	6.09e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.61e-05	5.81e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.56e-05	5.69e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.54e-05	5.65e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.51e-05	5.58e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—NOS3—esophageal cancer	2.49e-05	5.55e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.46e-05	5.46e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.28e-05	5.08e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—NOS3—esophageal cancer	2.27e-05	5.06e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.17e-05	4.83e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—EP300—esophageal cancer	2.13e-05	4.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.08e-05	4.63e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—NOS3—esophageal cancer	1.94e-05	4.32e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—EP300—esophageal cancer	1.9e-05	4.22e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PTGS2—esophageal cancer	1.78e-05	3.96e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—EP300—esophageal cancer	1.73e-05	3.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.68e-05	3.73e-05	CbGpPWpGaD
Gemfibrozil—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.57e-05	3.5e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—NOS3—esophageal cancer	1.5e-05	3.34e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—EP300—esophageal cancer	1.48e-05	3.29e-05	CbGpPWpGaD
Gemfibrozil—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.4e-05	3.12e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.37e-05	3.05e-05	CbGpPWpGaD
Gemfibrozil—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.28e-05	2.85e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—EP300—esophageal cancer	1.14e-05	2.54e-05	CbGpPWpGaD
Gemfibrozil—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.09e-05	2.43e-05	CbGpPWpGaD
Gemfibrozil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	8.44e-06	1.88e-05	CbGpPWpGaD
